A multidisciplinary team of scientists led by Carlo Ballatore, Ph.D., at University of California San Diego and Kurt Brunden, Ph.D., at the University of Pennsylvania has been awarded a $6.9 million grant from the National Institute on Aging (NIA) to prepare a potential disease-modifying Alzheimer’s treatment for future clinical trials.
DeepScribe Appoints Dr. Dean Dalili as Chief Medical Officer
Dr. Dean Dalili, MD, MHCM, Chief Medical Officer at DeepScribe What You Should Know: – DeepScribe, an innovator in ambient AI documentation for healthcare, announced
May 7, 2024